Jesse R. Qualliotine

Johns Hopkins University, University of California, San Francisco

Papers

2

Total Citations

126

H-Index

2

About

Jesse R. Qualliotine is a head and neck surgeon and researcher whose work centers on the intersection of human papillomavirus (HPV) and squamous cell carcinoma of the head and neck. His key research areas include HPV-associated oropharyngeal cancer, unknown primary squamous cell carcinoma (UPSCC), and the optimization of treatment strategies to improve patient quality of life. His most impactful contribution is his 2016 study on changes in UPSCC at initial presentation in the HPV era, which has garnered 119 citations. This work demonstrated that HPV positivity in UPSCC strongly orients the search for the primary tumor toward the oropharynx, fundamentally shifting diagnostic paradigms. Dr. Qualliotine has also advanced the field with a 2023 prospective study on quality of life outcomes for HPV-positive oropharynx cancer patients treated with surgery alone, showing that de-escalated surgical approaches can preserve function without compromising oncologic control. His research bridges virology, surgical oncology, and patient-reported outcomes, offering a more nuanced understanding of how to treat HPV-driven head and neck cancers. With a growing citation footprint, Dr. Qualliotine is establishing himself as a key voice in the movement toward personalized, less morbid therapies for this patient population.

Research Focus

Key Achievements

2
H-Index
2
Papers
126
Total Citations
63
Avg Citations/Paper
🏆 Most Cited Paper
Changes in Unknown Primary Squamous Cell Carcinoma of the Head and Neck at Initial Presentation in the Era of Human Papillomavirus
119 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Johns Hopkins University, University of California, San Francisco

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago